The stock of Brookfield Corporation (NYSE:BN) decreased by -$0.77 on Tuesday to finish at $35.14, down -2.14 percent. The last five days have seen an average of 2,285,380 shares of common stock traded. 14 times new highs were reached in the current year, with a gain of $3.68. The average number of shares traded over the last 20 days was 1,953,805, while the average volume over the last 50 days totaled 2,158,862.
BN stock appreciated 6.23% since last month. On 08/22/23, the company’s shares reached a one-month low of $31.65. The stock touched a high of $39.46 on 02/09/23, after rallying from a low of $28.25 in 52 weeks. The price of BN stock has risen by 11.70% or $3.68 this year, reaching a new high 14 times. Still, the stock price is down -10.95% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
BN stock investors should be aware that Brookfield Corporation (BN) stock had its last reported insider trading activity 90 days ago on Jun 22. On Jun 22, 10% Owner OCM Opps EB Holdings Ltd. sold 3,781,561 shares at $58.00 each. This transaction resulted in the insider making $219,330,538. On Mar 29, Brookfield Multi-Strategy Mast sold 50,256 shares at a price of US$11.94. After the transaction, the insider now owns 21,054,667 shares. Director Brookfield Multi-Strategy Mast had earlier sold 24,744 shares on Mar 28 for $11.96 a share. The transaction was completed for $295,988.
Valuation Metrics
Brookfield Corporation (BN) has a trailing price-to-earnings (P/E) ratio of 377.85. Beta for the stock is 1.42. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.61, the price-to-book (PB) ratio of 1.36.
Company paid $0.07 per share in dividends, remained unchanged from $0.07 last year.
Financial Health
The company’s long-term debt to equity ratio for the quarter ending June 29 is 5.38, and the total debt to equity ratio is 5.43. As far as profitability goes, gross margin for the trailing twelve months is 15.70% percent. Brookfield Corporation’s operating margin stood at 4.20% for the same period. Based on annual data, it had gross profit of $14.26 billion and revenue of $92.77 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. BN’s return on assets (ROA) during the last 12 months has been 0.00%. There was a 2.00% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 0.40%.
Earnings Surprise
According to Brookfield Corporation’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. It was predicted that Brookfield Corporation’s quarterly earnings would be $0.04, but it ended up being $0.87, beating the consensus by -95.40%. EBITDA was $5.95 billion for the quarter. At the end of Brookfield Corporation’s most recent quarter ended June 29, its liabilities totaled 307.55 billion, while its total debt was $219.7 billion.
Technical Picture
Here’s a quick look at Brookfield Corporation’s (BN) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 56.54%, suggesting the stock is Neutral, with a 22.78% historical volatility rate.
The stochastic %K and %D were 83.43% and 91.10% respectively, while the average true range (ATR) was 0.82. Based on the 14-day stochastic reading of 64.82%, the RSI (14) reading is 56.77%. On the 9-day MACD Oscillator, the stock is at 0.62, and the 14-day reading is at 0.99.
Analyst Ratings
Brookfield Corporation (NYSE: BN) was downgraded by Canaccord Genuity to a a Hold rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Brookfield Corporation (BN) an Overweight rating. BN is a stock that is recommended for selling by 0 brokerage firms, while 2 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 1 rate it overweight and 7 others recommend it as a buy.
What is BN’s price target for the next 12 months?
The current consensus forecast for the stock is between $33.00 and $65.00, with a median target price of $47.00. In analyzing these forecasts, the average price target given by analysts for Brookfield Corporation (BN) is $47.20.
